Picture of Hepion Pharmaceuticals logo

HEPA Hepion Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Hepion Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

R2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments13.940.791.351.214.8
Prepaid Expenses
Total Current Assets14.442.697.556.517.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.8550.6650.4560.1320.242
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets20.648.610460.218.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities1.614.668.217.895.29
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities4.998.1210.610.410.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity15.640.59349.97.28
Total Liabilities & Shareholders' Equity20.648.610460.218.1
Total Common Shares Outstanding
Total Preferred Shares Outstanding